New study using DSS reveals cyclin A2 as a prognostic factor in colorectal cancer

A new article in Journal of Clinical Investigations is clarifying the protective role of cyclin A2 in colorectal cancer and revealing a new independent prognosis factor for CRC tumors. The authors used dextran sulfate sodium salt (DSS) from TdB Labs to chemically induced colon carcinogenesis. Read the full study here (open access) here.

We congratulations all authors!

#DSS #dextran #colorectalcancer #cancerresearch #inflammation #invivo #oncologyresearch

  • Sign up for our newsletter

More news

Summer Holidays

  • Nyhet

New US distributor

  • Nyhet

 

BonaPostualata20

 

What do you think about this website?